title: Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.
abstract: Insertional mutagenesis of the spi-1 gene is associated with the emergence of malignant proerythroblasts during Friend virus-induced acute erythroleukemia. To determine the role of spi-1/PU.1 in the genesis of leukemia, we generated spi-1 transgenic mice. In one founder line the transgene was overexpressed as an unexpected-size transcript in various mouse tissues. Homozygous transgenic animals gave rise to live-born offspring, but 50% of the animals developed a multistep erythroleukemia within 1.5 to 6 months of birth whereas the remainder survived without evidence of disease. At the onset of the disease, mice became severely anemic. Their hematopoietic tissues were massively invaded with nontumorigenic proerythroblasts that express a high level of Spi-1 protein. These transgenic proerythroblasts are partially blocked in differentiation and strictly dependent on erythropoietin for their proliferation both in vivo and in vitro. A complete but transient regression of the disease was observed after erythrocyte transfusion, suggesting that the constitutive expression of spi-1 is related to the block of the differentiation of erythroid precursors. At relapse, erythropoietin-independent malignant proerythroblasts arose. Growth factor autonomy could be partially explained by the autocrine secretion of erythropoietin; however, other genetic events appear to be necessary to confer the full malignant phenotype. These results reveal that overexpression of spi-1 is essential for malignant erythropoiesis and does not alter other hematopoietic lineages.
authors.affiliation: INSERM U248, Institut Curie, Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Moreau-Gachelin
authors.forename: F
authors.initials: F
authors.lastname: Wendling
authors.forename: T
authors.initials: T
authors.lastname: Molina
authors.forename: N
authors.initials: N
authors.lastname: Denis
authors.forename: M
authors.initials: M
authors.lastname: Titeux
authors.forename: G
authors.initials: G
authors.lastname: Grimber
authors.forename: P
authors.initials: P
authors.lastname: Briand
authors.forename: W
authors.initials: W
authors.lastname: Vainchenker
authors.forename: A
authors.initials: A
authors.lastname: Tavitian
mesh_terms: D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D004268:DNA-Binding Proteins / Q000096:biosynthesis* / Q000235:genetics; D005091:Exons; D005622:Friend murine leukemia virus / Q000235:genetics; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000473:pathology; D006720:Homozygote; D004915:Leukemia, Erythroblastic, Acute / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology; D008099:Liver / Q000166:cytology / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D016254:Mutagenesis, Insertional; D009928:Organ Specificity; D015682:Retroviridae Proteins, Oncogenic / Q000096:biosynthesis / Q000235:genetics; D013154:Spleen / Q000166:cytology / Q000473:pathology; D014158:Transcription, Genetic; D014162:Transfection
chemical_list: D004268:DNA-Binding Proteins; D015682:Retroviridae Proteins, Oncogenic; C062022:v-Spi-1 protein, Friend spleen focus-forming virus